Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 22, 1997

View Archived Issues

Chlorhexidine solution prevents perinatal infections

ISO 9001 given to Senetek for drug delivery system

EchoGen enters phase III trials

FDA approves hand implant for quadriplegics

Medco and Discovery Therapeutics announce R&D alliance

Gene interaction studies without blood tests

Receptor Technologies announces name change

FDA clears ChromaFlo option for Oracle Invision ultrasound

Meretek UBT breath test for H. pylori now offered by first test center

HIV-O licensed to Abbott

Lasette laser finger perforator receives FDA clearance

Cerebrus develops novel animal satiety model

Murex launches E. coli O157 assay

Second gene discovered that delays AIDS

Interneuron: Q3 1997 highlights

Telomerase-inhibitory oligonucleotides for treating cancer

Apoptosis modulators reported in patent literature

Alexion reports novel retroviral vectors for gene therapy

Melatonin implant delays puberty in rats

Link established between estradiol and melatonin production in adult rats

Supplemental NDA approved for Cipro

Alpha-adrenoceptors may be implicated in obesity

New COX-2 inhibitor series reported by Searle

Living human tissue approved for marketing in Canada

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...